Back to report

Cardinal Health: huge drug-distribution scale still has to prove margin and balance-sheet quality

CAHResearch reportPosted by Goglides ResearchMay 20, 2026
NYSECAHCoverage BootstrapCardinal Health, Inc.

Thesis summary

CAH has an annual revenue baseline of $222.6B, latest revenue marker of $129.6B first half fiscal 2026 companyfacts frame, annual net income of $1.6B and cash of $2.8B latest companyfacts cash frame. The thesis depends on revenue durability, margins, cash conversion and balance-sheet discipline.

View article

CAH has an annual revenue baseline of $222.6B, latest revenue marker of $129.6B first half fiscal 2026 companyfacts frame, annual net income of $1.6B and cash of $2.8B latest companyfacts cash frame. The thesis depends on revenue durability, margins, cash conversion and balance-sheet discipline.

View full article

Discuss the thesis

0 comments
Commenting requires active membershipBecome a member
Attack the thesis, not the person.Add evidence when challenging claims.No pump, spam, or low-effort comments.

No comments yet. Start the discussion with evidence, a question, or a bear case.